Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

The National Pharmaceutical Pricing Authority (NPPA) has issued the revised ceiling price of iohexol injection 300 mg iodine per ML, a diagnostic agent, with a 14.8 percent reduction from the existing ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Shanghai-based VelaVigo has been busy. The biotech granted Avenzo Therapeutics ex-China rights to a Nectin4xTROP2 bispecific antibody-drug conjugate in November, netting up to $50 million in ...

Administered as a single injection, it represents a type of treatment using lab-made proteins known as monoclonal antibodies, which can cut off your body's allergic response at its source.

China’s central bank is boosting cash injection via one of its policy tools as it seeks to safeguard the world’s second-largest economy from the impact of punitive US tariffs. The People’s ...

The new company is led by CEO Caroline Loew, a biotech veteran with experience at Blympse Bio, Bristol-Myers Squibb, and Merck. Mural Oncology has offices in Dublin, Ireland, but its primary ...

For decades, the United States has led the world in biotech and pharmaceutical innovation. But our dominance is now at risk: not from external sabotage, but from our own regulatory sclerosis.

At the time, the company said it had brought in TD Cowen to help the biotech “identify opportunities to maximize shareholder value through a strategic transaction and/or business combination.” ...

His ousting of Peter Marks—a senior official at the Food and Drug Administration and key proponent of faster drug approvals—sent biotech stocks tumbling last month and stoked concerns that the ...

One such contender is Syntis Bio, a Boston-based biotech firm working on an oral ... Unlike GLP-1 drugs, which are administered via injection and often come with side effects such as nausea ...

After San Francisco biotech company Third Harmonic Bio slashed its staff by half in February, it’s now taking a more drastic step. The inflammatory disease research company’s directors have ...